BD FACSAria II

基本信息

批准号：
7839735
负责人：
MICHAEL CLARKE
金额：
$ 66.39万
依托单位：
STANFORD UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-08-15 至 2011-08-14
项目状态：
已结题

项目摘要

DESCRIPTION (provided by applicant): We are requesting funds for the purchase of a state-of-the art fluorescence activated cell sorter (FACS), the BD Biosciences FACSAria II, to support research projects in the newly established Institute of Stem Cell Biology and Regenerative Medicine (ISCBRM) at Stanford University School of Medicine. The ISCBRM is expanding rapidly, with three new faculty members added in the last two years, and another two being added in 2009. FACS is the key platform technology for all aspects of the research at ISCBRM, including the identification, isolation, and characterization of highly purified subsets of stem and progenitor cells from normal tissues, and cancer stem cells from a wide variety of malignant tissues. Due to the rarity of the stem cell populations isolated in our FACS sorts, each sort routinely requires a minimum of two to four hours. In addition, most experiments require two sequential sorting runs to adequately remove contaminating cells. So individual experiments can require 4-8 hours of FACS sorting time. The increased staffing at ISCBRM, combined with the fact that all faculty members require long hours of FACS sorting of their cells of interest, has recently led to a bottleneck in terms of flow cytometry access, and this is significantly impeding scientific progress. Another consideration that further underscores our need for an additional FACS is that many projects at ISCBRM use human cancer tissues which are received at short notice, often with no more than a few hours to 1-2 days before sorting of the live cells must be executed. This situation requires a flow cytometry capacity with sufficient flexibility in scheduling and availability to accommodate samples at short notice. The intensive use of our current FACS facility makes it almost impossible to handle samples at short notice, and there have been many occasions when precious and rare clinical samples have been wasted. The following proposal lists the faculty members who need additional FACS access, and describes the projects in their labs that require extensive FACS sorting time. We are specifically requesting a BD Biosciences FACSAria II because each of the projects described herein requires multi-parameter sorting. In summary we have a pressing need to purchase a FACSAria II to relieve our current flow cytometry access bottleneck and thereby accelerate our progress in stem cell research, and to provide sufficient scheduling flexibility to be able to handle extremely valuable clinical samples at short notice.

描述（由申请人提供）：我们正在申请资金购买最先进的荧光激活细胞分选仪（FACS）BD Biosciences FACSAria II，以支持新成立的干细胞生物学研究所和斯坦福大学医学院再生医学（ISCBRM）。 ISCBRM 正在迅速扩张，过去两年增加了三名新教员，2009 年又增加了两名。FACS 是 ISCBRM 研究各个方面的关键平台技术，包括识别、分离和表征来自正常组织的高度纯化的干细胞和祖细胞亚群，以及来自多种恶性组织的癌症干细胞。由于我们的 FACS 分选中分离的干细胞群非常稀有，每次分选通常至少需要两到四个小时。此外，大多数实验需要两次连续的分选运行以充分去除污染细胞。因此，单个实验可能需要 4-8 小时的 FACS 分选时间。 ISCBRM 人员配备的增加，加上所有教员都需要长时间对其感兴趣的细胞进行 FACS 分选，最近导致了流式细胞术获取方面的瓶颈，这严重阻碍了科学进步。进一步强调我们需要额外 FACS 的另一个考虑因素是，ISCBRM 的许多项目都使用在短时间内收到的人类癌症组织，通常在必须执行活细胞分选之前不超过几个小时到 1-2 天。。这种情况需要流式细胞术能力具有足够的调度灵活性和可用性，以在短时间内容纳样品。我们现有的 FACS 设施的大量使用使得几乎不可能在短时间内处理样品，并且在很多情况下都浪费了珍贵和稀有的临床样品。以下提案列出了需要额外 FACS 访问权限的教员，并描述了其实验室中需要大量 FACS 分类时间的项目。我们特别请求 BD Biosciences FACSAria II，因为本文描述的每个项目都需要多参数排序。综上所述，我们迫切需要购买FACSAria II来缓解我们当前的流式细胞术接入瓶颈，从而加快我们在干细胞研究方面的进展，并提供足够的调度灵活性，以便能够在短时间内处理极其有价值的临床样本。